A significant overhaul of New Zealand’s publicly funded science, innovation and technology sector got underway this week. The government’s goal is to transition toward a simpler, more strategic system. A system actively translating research and ideas into high-value commercial solutions that contribute to economic growth. The sometimes controversial reform comes with a $40 million carrot in the form of a long awaited and substantial increase to funding for commercialisation support services.
Foreshadowed in 2025, a central feature of the reform is the introduction of a new outcomes-focused funding framework built around four distinct priority domains: advanced technology, the economy, the environment and health and society. Rather than managing fragmented funding pools, decision-making will now be streamlined. A single, independent entity called Research Funding New Zealand (RFNZ) has been established to consolidate and manage the majority of the system’s research allocations. RFNZ will determine funding distributions based on strategic research priorities set out in a long-term Science Investment Plan, which itself is guided by the Prime Minister’s Science, Innovation and Technology Advisory Council.
Directly aligning with this strategic shift is a major funding boost focused on university research commercialisation. The government is investing $40.68 million dollars over three years to better bridge the gap between academic discovery and market application. Previously unannounced, the funding has been broadly welcomed by both researchers and commercialisation organisations. Rolling out with an initial pilot in 2026, the funding will substantially enhance the existing Commercialisation Partner Network and will be paired with co-investment from New Zealand universities to increase overall impact.
Crucially, this financial backing is reinforced by structural policy changes designed to encourage researcher entrepreneurship. A new national Intellectual Property (IP) Management Policy now gives university researchers far greater control over their own inventions, including the right to elect a particular commercialisation pathway outside of the host research institution within 90 days of disclosure. This provides greater clarity around incentives for both research and institution. Additionally, new commercialisation engagement guidelines have been established to streamline collaborative efforts between researchers, academic institutions, and private industry partners.
Several publicly funded programs are being shuttered to provide cash for more business focused initiatives. This has led some commentators in the research community to bemoan the loss of funding for “blue skies” research, a type of research in which there is no particular economic goal in mind at the outset. Blue skies style science research is certainly not without its merits however. Some of the late Sir Paul Callaghan’s research into nuclear magnetic resonance was funded this way. But in recent years the work has produced several high tech spinoff companies including Wellumio, developer of a lightweight portable MRI scanner.
With a largely agrarian economy reliant on exports of primary produce, New Zealand’s innovation performance and research investment has substantially underperformed compared to other OECD countries. Reform can be painful and the NZ government has certainly herded some sacred cows into the back paddock (for the time being at least). The new unified funding and policy arrangements should establish a far more dynamic, responsive, and commercially viable publicly funded innovation system for New Zealand. But to fully succeed, the new support system funding will need be addressed toward a truly ecosystem based approach.
Genius ReFi connects researchers, investors, entrepreneurs and industry players interested in the commercialisation of science.
Image credit: Midnighttonight CC BY-SA 3.0 via Wikimedia Commons
